Harbourvest Partners’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.2K | Hold |
29,018
| – | – | 0.02% | 15 |
|
2025
Q1 | $13.8K | Hold |
29,018
| – | – | 0.01% | 15 |
|
2024
Q4 | $29.3K | Hold |
29,018
| – | – | 0.01% | 21 |
|
2024
Q3 | $49.6K | Hold |
29,018
| – | – | 0.03% | 28 |
|
2024
Q2 | $74K | Hold |
29,018
| – | – | 0.04% | 32 |
|
2024
Q1 | $121K | Hold |
29,018
| – | – | 0.06% | 40 |
|
2023
Q4 | $96.3K | Hold |
29,018
| – | – | 0.03% | 46 |
|
2023
Q3 | $58K | Hold |
29,018
| – | – | 0.02% | 54 |
|
2023
Q2 | $91.7K | Hold |
29,018
| – | – | 0.03% | 54 |
|
2023
Q1 | $101K | Hold |
29,018
| – | – | 0.03% | 55 |
|
2022
Q4 | $149K | Hold |
29,018
| – | – | 0.05% | 56 |
|
2022
Q3 | $287K | Buy |
29,018
+14,387
| +98% | +$142K | 0.09% | 54 |
|
2022
Q2 | $123K | Hold |
14,631
| – | – | 0.04% | 58 |
|
2022
Q1 | $184K | Hold |
14,631
| – | – | 0.04% | 62 |
|
2021
Q4 | $232K | Buy |
+14,631
| New | +$232K | 0.03% | 59 |
|